Awake prone positioning reduces mortality, intubation, and hospital stay in acute hypoxemic respiratory failure: a systematic review and meta-analysis of 6,164 patients.

Publication date: May 28, 2026

Acute hypoxemic respiratory failure (AHRF) is a major cause of morbidity and mortality and often requires advanced respiratory support. Awake prone positioning (APP) has emerged as a simple, low-cost intervention to improve oxygenation in non-intubated patients; however, its clinical effectiveness and safety remain uncertain. This systematic review and meta-analysis aimed to evaluate the effectiveness and safety of awake prone positioning in non-intubated adult patients with acute hypoxemic respiratory failure. A systematic search of PubMed, Scopus, and Web of Science was conducted from database inception to February 2026. Randomized controlled trials and observational comparative studies evaluating APP versus usual care were included. Primary outcomes were mortality, intubation, and length of hospital stay. Secondary outcomes included ICU stay, invasive mechanical ventilation, ICU admission, escalation of respiratory support, time to invasive ventilation, and adverse events. Risk of bias was assessed using ROB 2 for randomized trials and the Newcastle-Ottawa Scale for observational studies. Meta-analysis was performed using a random-effects model. Twenty-four studies involving 6,164 patients were included. APP significantly reduced mortality (OR = 0. 60, 95% CI 0. 42-0. 86, p = 0. 005), intubation (OR = 0. 69, 95% CI 0. 60-0. 79, p 

Open Access PDF

Concepts Keywords
Anesthesiol Awake prone positioning
February COVID-19
Morbidity Intubation
Rob Mechanical ventilation
Stay Meta-analysis
Mortality

Semantics

Type Source Name
disease MESH acute hypoxemic respiratory failure
disease MESH included
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease MESH COVID 19
drug DRUGBANK Oxygen
disease MESH acute respiratory distress syndrome
disease MESH lung injury
disease MESH hypoxemia
disease MESH clinical deterioration
disease MESH ventilator induced lung injury
disease MESH strain
disease MESH vomiting
disease MESH cardiac arrest
disease MESH death
disease MESH SaO
drug DRUGBANK Carbon dioxide
drug DRUGBANK Trimebutine
disease MESH MAE
disease MESH pain
disease MESH Dis
disease MESH Critical Illness
disease MESH Roca
drug DRUGBANK Spinosad
disease MESH Pneumonia
disease MESH Infection
drug DRUGBANK Carboxyamidotriazole

Original Article

(Visited 5 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *